Current Trials

Ongoing Trials

Anifrolumab (NCT05138133) - Lupus Nephritis 

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: AstraZeneca

Phase: 3 

Accrual Status: Recruiting

Rayulizumab (NCT04564339) - Lupus Nephritis

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Alexion Pharmaceuticals, Inc. 

Phase: 2

Accrual Status: Active, not recruiting

Rayulizumab (NCT06291376) - IgA Nephropathy

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Alexion Pharmaceuticals, Inc.

Phase: 3

Accrual Status: Recruiting

Atacicept (NCT04716231) - IgA Nephropathy

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Vera Therapeutics, Inc.

Phase: 3

Accrual Status: Recruiting

Sefaxersen (NCT05797610) - IgA Nephropathy

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Hoffman-La Roche

Phase 3:

Accrual Status: Pending open to accrual

Iptacopan (NCT04578834) - IgA Nephropathy

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Novartis Pharmaceuticals

Phase: 3

Accrual Status: Active, not recruiting

DISC-0974 (NCT05745883) - CKD

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Disc Medicine, Inc.

Phase: 1b

Accrual Status: Recruiting

Finerenone (NCT05047263) - CKD

View Clinical Trial(Link is external)

Sponsor: Bayer

Phase: 3

Accrual Status: Active, not recruiting

Vonafexor (NCT06425055) - Alport Syndrome

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Enyo Pharma

Phase: Proof-of-concept study

Accrual Status: Active, not recruiting

Prismocitrate 18 (NCT05399537) - Renal Replacement Therapy

View Clinical Trial(Link is external)

Sponsor: Baxter

Phase: 3

Accrual Status: Pending open to accrual

Observational Program (NCT00196742) - Fabry

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Genzyme, a Sanofi company

Phase: Registry

Accrual Status: Recruiting

HM15421/GC1134A - Fabry

Sponsor: Hanmi Pharmaceutical Co. LTF., GC Biopharma Corp

Phase 1/2

Accrual Status: Pending open to accrual

Venglustat (NCT05280548) - Fabry

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Sanofi

Phase: 3

Accrual Status: Active, not recruiting

FabrazymE (NCT06019728) - Fabry

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Sanofi

Phase: 4

Accrual Status: Active, not recruiting

Venglustat (NCT05206773) - Fabry

View Clinical Trial(Link is external) (Link opens in new window)

Sponsor: Sanofi

Phase: 3

Accrual Status: Active, not recruiting

Repagermanium (NCT05183646) - FSGS

View Clinical Trial(Link is external)

Sponsor: Dimerix Bioscience Pty Ltd

Phase: 3

Accrual Status: Pending open to accrual

ABBV-CLS-628 - ADPKD

Sponsor: Abbvie

Phase: 2

Accrual Status: Pending open to accrual